Singapore markets close in 11 minutes
Straits Times Index
3,327.90 -2.19 (-0.07%) Nikkei
38,556.87 -298.50 (-0.77%) Hang Seng
18,477.01 -344.15 (-1.83%) FTSE 100
8,239.69 -14.49 (-0.18%) Bitcoin USD
67,716.48 -460.55 (-0.68%) CMC Crypto 200
1,461.29 -23.40 (-1.58%)
PFE Dec 2024 26.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:36PM EDT. Market open.
| Previous close | 1.1400 |
| Open | 1.0400 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 26.00 |
| Expiry date | 2024-12-20 |
| Day's range | 1.0400 - 1.1500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksPfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ZacksPharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
ZacksPfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
This is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first phase of this program is expected to save nearly $1.5 billion by 2027-end.
© 2024 Yahoo. All rights reserved.